Hepatocellular transplantation in acute liver failure

Area of Science:

• Hepatology
• Regenerative Medicine
• Toxicology

Background:

• Acute liver failure has high mortality, with limited effective temporary support options.
• Successful liver recovery depends on metabolic support during a critical healing period.

Purpose of the Study:

• To evaluate the efficacy of dispersed hepatocyte transplantation for metabolic support in drug-induced acute liver failure.
• To assess survival rates and liver recovery following hepatocyte transplantation.

Main Methods:

• Acute liver failure was induced in rats using dimethylnitrosamine (DMNA).
• Hepatocytes were transplanted intraperitoneally or via the portal vein 24 hours post-DMNA administration.
• Control groups received saline infusion or no treatment.

Main Results:

• Hepatocyte-treated groups showed significantly higher survival rates (63% and 71%) compared to controls (17% and 6%) at 3 weeks.
• Serum glutamic oxaloacetic transaminase (SGOT) levels indicated equivalent liver damage across groups initially.
• Histology confirmed liver regeneration in surviving animals, with transplanted hepatocytes observed in liver vasculature.

Conclusions:

• Dispersed hepatocyte transplantation, via intraperitoneal or portal vein routes, provides effective metabolic support.
• This approach facilitates recovery from drug-induced hepatic necrosis and improves survival in acute liver failure models.